Chris Boedeker, in a bizarre political attack ad released Wednesday, said state Rep. Scott Holcomb opposed a welfare drug testing bill this year because he's a drug user.
The Republican House District 81 seat challenger quickly removed the ad from YouTube after it was uploaded, however, once it became the subject of negative press attention.
From The Huffington Post, which was given a copy of the ad:
"Representative Scott Holcomb brags about his military experience," the ad's narrator says. "Scott Holcomb talks about using illegal drugs while in the service, which is why he now opposes drug tests for people who receive welfare benefits."
The ad then shows a clip of Holcomb speaking against a welfare drug testing bill on the floor of the Georgia House of Representatives earlier this year. Holcomb said he knew from his own experience in the Army that drug testing could be a difficult process.
"As someone who went through that ... I would always get the call after I had -- you know," Holcomb says in the clip. Ominous music sounds, and the narrator asks, "What is Scott Holcomb smoking?"
In a longer clip of Holcomb's remarks, it's apparent Holcomb's problem was that he always got the call to take a drug test after he had peed.
Read the HuffPo story for more information.
Holcomb took to his Twitter account, condemning the ad:
"[I am] pretty sure my opponent was sick the day they taught law at law school. He's also a coward and a liar and unfit for public service.#gapol
House Democrats released a statement Friday afternoon supporting Holcomb.
“One of our fundamental values as a nation is to honor those who serve our families and neighbors,” said Caucus Chairman Brian Thomas, a retired Army Major, in the statement. “It is inconceivable that anyone would dishonor a veteran who put his life on the line to protect our country and freedom. We are calling on our State’s Republican leadership to denounce Mr. Boedeker’s false statements against fellow U.S. veteran, Rep. Holcomb.”
Boedecker did not immediately return a call for comment.
More to follow...